Lucie Brujin, Ph.D. MBA
Current position: TAL, BMD, NIBR, Novartis 2019-present
I have worked in the neurodegenerative field for the past 28 years with a specific interest in developing therapies for these devastating disorders. As Therapeutic Area Lead for ALS at Novartis I oversea therapeutic strategies and biomarker development for antibody, small molecule and gene therapy assets. Prior to joining Avexis, Gene Therapies and now Novartis, as Chief Scientist at The ALS Association, I established the first translational research program for ALS, Translational Research Advancing Therapies for ALS (TREAT ALS). Through partnerships between academia, government and industry and soliciting donor contributions for strategic programs, I established initiatives for drug development, clinical trials, biomarkers, assistive
HEADQUARTERS & ADMINISTRATION
53 Rothschild Boulevard
PO Box 68
Tel Aviv, 6100001, Israel
Tel: +972-3-5666166
Fax: +972-3-5666177
office@comtecmed.com
COMTEC SPAIN
Bailen, 95 – 97
pral.1.a – 08009
Barcelona, Spain
Tel: +34-932081145
Fax: +34-934579291
spain-office@comtecmed.com
COMTEC CHINA
Suite 405, Universal Center Building
175 Xiang Yang Road South
Shanghai 200031, China
Tel: +86-21-54660460
Fax: +86-21-54660450
china-office@comtecmed.com
COMTEC USA
415 South Street
POB #3627
Waltham, MA 02453-2700
Tel: +1-914-312-5407
Fax: 972-3-566-6177
usa-office@comtecint.com